<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="15533" OLDID="4711" TOPICS="NO">
<DATE> 9-APR-1987 09:41:33.99</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 

   F
   f0895 reute
r f BC-SENETEK-&lt;SNTKY&gt;-UNIT   04-09 0110</UNKNOWN>
<TEXT> 
<TITLE>SENETEK &lt;SNTKY&gt; UNIT TO MARKET AIDS TEST</TITLE>
<DATELINE>    MOUNTAIN VIEW, Calif., April 9 - </DATELINE><BODY>Senetek PLC said its
Senetek A/S Danish subsidiary has signed a letter of intent to
market &lt;Diagnostic Biotechnology Co Pt Ltd&gt; of Singapore's AIDS
antibody tests to the health care industries in Britain and the
Scandinavian countries.
    The company said its 49 pct owned Tessek Ltd joint venture
affiliate in Prague has also signed a letter of intent to
market Diagnostics AIDS tests in Czechoslovakia and other
Comecon countries.   It said Tessek has agreed to exchange
research information with Diagnostic in the development of a
new AIDS diagnostic kit using Tessek technology.
 Reuter
 </BODY></TEXT>
</REUTERS>